Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-25 @ 9:50 PM
Study NCT ID:
NCT03951051
Status:
COMPLETED
Last Update Posted:
2019-07-29
First Post:
2019-05-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.
Sponsor:
Pharmtechnology LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-06
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-16
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-13
First Submit QC Date:
None
Study First Post Date:
2019-05-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-26
Last Update Post Date:
2019-07-29
Last Update Post Date Type:
ACTUAL